Skip to main content
Log in

Aducanumab

Amyloid rebound in Alzheimer's disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Patel S, et al. Treatment interval dependent effects of aducanumab therapy on Alzheimer's disease neuropathology. Journal of Neuropathology and Experimental Neurology 82 : 489-490, No. 6, Jun 2023. Available from: URL: http://doi.org/10.1093/jnen/nlad029 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aducanumab. Reactions Weekly 1966, 21 (2023). https://doi.org/10.1007/s40278-023-43474-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-43474-y

Navigation